<DOC>
	<DOCNO>NCT00002063</DOCNO>
	<brief_summary>Primary : To determine clinical effect zidovudine ( AZT ) compare placebo term time progression AIDS ( i.e. , occurrence major opportunistic infection , dementia , malignancy ) death . Initial drug assignment change open-label AZT patient experience sustain decline CD4 lymphocyte concentration le 200 cells/mm3 , analysis base initial treatment assignment . To determine immunologic effect AZT compare placebo term time drop CD4 lymphocyte concentration least 25 percent baseline assessment . To determine antiviral effect AZT compare placebo eradicate suppress HIV . Secondary : To determine effect AZT compare placebo immune status HIV-infected patient compare lymphocyte profile index . To determine long-term toxicity AZT compare placebo term abnormality BL , hepatic function , renal function , skin , gastrointestinal system , central nervous system . To describe natural history AIDS relate complex ( ARC ) placebo patient term initial CD4 lymphocyte concentration Walter Reed stag system .</brief_summary>
	<brief_title>Treatment AIDS AIDS Related Complex . Part-1- Treatment Patients With ARC ( AZT Vs . Placebo )</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>AIDS-Related Complex</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Inclusion Criteria Patient must AIDS relate complex ( ARC ) define Walter Reed stage , ambulatory , able give inform consent . Exclusion Criteria Coexisting Condition : Patients unstable disease characterize follow exclude : Hospitalization within past 14 day . Major opportunistic infection , current past . An active infection onset past 30 day , evidence symptom , sign , laboratory abnormality : Temperature = &gt; 100.5 degree F. Night sweat . Weight loss = &gt; 10 percent body weight . Diarrhea ( 3 bowel movements/day ) . Persistent cough , shortness breath , dyspnea exercise . Abnormal chest xray suggest pneumonia increase arterialalveolar ( Aa ) gradient . Altered mental status , seizure , focal neurologic sign . Abnormal computerized tomography ( CT ) scan magnetic resonance imaging ( MRI ) suggestive toxoplasmosis , peripheral mononuclear leukocyte , lymphoma , focal abnormality central nervous system ( CNS ) . Abnormal cerebrospinal fluid ( CSF ) suggestive cryptococcal , mycobacterial , meningitis . ( The decision perform invasive test , lumbar puncture , specialized microbiological test bone marrow culture Mycobacteria Histoplasma capsulatum , specialized radiological test CT scan MRI base clinical assessment patient . ) Kaposi 's sarcoma . Lymphoma ; malignancy require chemotherapy . Dementia . Requiring hemodialysis renal insufficiency failure . Leukopenia . Thrombocytopenia . Patients follow exclude : Unstable disease . Kaposi 's sarcoma . Lymphoma ; malignancy require chemotherapy . Dementia . Major opportunistic infection , current past . Anemia ( hemoglobin le 9.5 g/dl ) . Prior Medication : Excluded within 1 month study entry : Ribavirin zidovudine ( AZT ) antiviral . Immunomodulating agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 1990</verification_date>
	<keyword>Immune Tolerance</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
</DOC>